Vecu

Metformin:

Decreases hepatic glucose production, decreases glucose absorption in the GIT, increases target cell insulin sensitivity.

 

Glimepiride:

Initial effect to increase insulin secretion from beta cells; may also decrease rate of hepatic glucose production and increase insulin receptor sensitivity.